The Influence of Tissue Ischemia on Biomarker Expression in Colorectal Cancer

被引:0
|
作者
Havelund, Birgitte M. [1 ,4 ]
Olsen, Dorte A. [2 ]
Andersen, Rikke F. [2 ]
Spindler, Karen-Lise G. [1 ,4 ]
Brandslund, Ivan [2 ,4 ]
Jakobsen, Anders [1 ,4 ]
Soerensen, Flemming B. [3 ,4 ]
机构
[1] Vejle Hosp, Dept Oncol, DK-7100 Vejle, Denmark
[2] Vejle Hosp, Dept Clin Biochem, DK-7100 Vejle, Denmark
[3] Vejle Hosp, Dept Clin Pathol, DK-7100 Vejle, Denmark
[4] Univ Southern Denmark, Inst Reg Hlth Serv Res, Odense, Denmark
关键词
biomarker; colorectal cancer; delayed fixation; hypoxia; ischemia; SURGICALLY INDUCED ISCHEMIA; PARAFFIN-EMBEDDED TISSUE; GENE-EXPRESSION; RECTAL-CANCER; FORMALIN FIXATION; WARM ISCHEMIA; COLON-CANCER; HYPOXIA; PROLIFERATION; PROTEIN;
D O I
暂无
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
The aim of the present study was to investigate the influence of fixation delay and the perioperative ischemia on hypoxia inducible factor (HIF)-1 alpha gene expression, HIF-1 alpha protein expression, and immunohistochemical (IHC) expression of HIF-1 alpha, GLUT-1, Bcl-2, and Ki-67 in colorectal cancer. The study included 25 surgically removed colorectal tumors. Three sets of samples were collected readily after removal and exposed to 0, 30, and 60 minutes of delay of fixation or freezing. The perioperative ischemia time was registered. In each set of the samples, HIF-1 alpha gene expression was analyzed by quantitative real time polymerase chain reaction, protein concentration of HIF-1 alpha was assessed by enzyme-linked immunosorbent assay, and IHC staining of HIF-1 alpha, GLUT-1, Bcl-2, and Ki-67 was performed. Preoperative formalin-fixed paraffin-embedded biopsies and whole sections of the entire tumor were analyzed by IHC. We found that the HIF-1 alpha gene expression, HIF-1 alpha protein concentration, and IHC expression of HIF-1 alpha, GLUT-1, Ki-67, and Bcl-2 were not systematically affected by either the fixation or freezing delay of the tissue, the perioperative ischemia time, or the total ischemia time (perioperative ischemia + delay of fixation or freezing) in colorectal tumors. However, the intraindividual variation was quite large, which may question the use of individually, non-standardized-handled single biopsies or small tissue samples for analysis of often rather heterogenously expressed biomarkers.
引用
收藏
页码:298 / 307
页数:10
相关论文
共 50 条
  • [21] Association of TET1 expression with colorectal cancer progression
    Tian, Yiping
    Pan, Feixia
    Sun, Xiaohui
    Gan, Meifu
    Lin, Aifen
    Zhang, Dandan
    Zhu, Yimin
    Lai, Maode
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017, 52 (03) : 312 - 320
  • [22] Adiponectin and resistin: biomarker for colorectal cancer?
    Wiwanitkit, Viroj
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2010, 25 (10) : 1257 - 1257
  • [23] Adiponectin and resistin: biomarker for colorectal cancer?
    Viroj Wiwanitkit
    International Journal of Colorectal Disease, 2010, 25 : 1257 - 1257
  • [24] Role of MGMT as biomarker in colorectal cancer
    Inno, Alessandro
    Fanetti, Giuseppe
    Di Bartolomeo, Maria
    Gori, Stefania
    Maggi, Claudia
    Cirillo, Massimo
    Iacovelli, Roberto
    Nichetti, Federico
    Martinetti, Antonia
    de Braud, Filippo
    Bossi, Ilaria
    Pietrantonio, Filippo
    WORLD JOURNAL OF CLINICAL CASES, 2014, 2 (12) : 835 - 839
  • [25] Differential expression proteomics of human colorectal cancer based on a syngeneic cellular model for the progression of adenoma to carcinoma
    Roth, Udo
    Razawi, Hanieh
    Hommer, Julia
    Engelmann, Katja
    Schwientek, Tilo
    Mueller, Stefan
    Baldus, Stephan E.
    Patsos, Georgios
    Corfield, Anthony P.
    Paraskeva, Christos
    Hanisch, Franz-Georg
    PROTEOMICS, 2010, 10 (02) : 194 - 202
  • [26] Emerging role of caldesmon in cancer: A potential biomarker for colorectal cancer and other cancers
    Alnuaimi, Alya R.
    Nair, Vidhya A.
    Malhab, Lara J. Bou
    Abu-Gharbieh, Eman
    Ranade, Anu Vinod
    Pintus, Gianfranco
    Hamad, Mohamad
    Busch, Hauke
    Kirfel, Jutta
    Hamoudi, Rifat
    Abdel-Rahman, Wael M.
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 14 (09) : 1637 - 1653
  • [27] BIOMOLECULAR PROFILE OF COLORECTAL CANCER - THE ROLE OF TELOMERASE AS A POTENT BIOMARKER
    Tsiaoussis, John
    Vassilopoulou, Loukia
    Nikolouzakis, Taxiarchis
    Rakitskii, Valerii N.
    Vakonaki, Eleni
    Fragkiadaki, Persefoni
    Stivaktakis, Polychronis
    Tsatsakis, Aristides M.
    FARMACIA, 2017, 65 (05) : 643 - 659
  • [28] POFUT1 as a Promising Novel Biomarker of Colorectal Cancer
    Chabanais, Julien
    Labrousse, Francois
    Chaunavel, Alain
    Germot, Agnes
    Maftah, Abderrahman
    CANCERS, 2018, 10 (11)
  • [29] Role of MGMT as biomarker in colorectal cancer
    Alessandro Inno
    Giuseppe Fanetti
    Maria Di Bartolomeo
    Stefania Gori
    Claudia Maggi
    Massimo Cirillo
    Roberto Iacovelli
    Federico Nichetti
    Antonia Martinetti
    Filippo de Braud
    Ilaria Bossi
    Filippo Pietrantonio
    World Journal of Clinical Cases, 2014, (12) : 835 - 839
  • [30] SCTRhypermethylation is a diagnostic biomarker in colorectal cancer
    Li, DaPeng
    Zhang, Lei
    Fu, JinMing
    Huang, Hao
    Sun, SiMin
    Zhang, Ding
    Zhao, LiYuan
    Onwuka, Justina Ucheojor
    Zhao, YaShuang
    Cui, BinBin
    CANCER SCIENCE, 2020, 111 (12) : 4558 - 4566